Results 231 to 240 of about 480,371 (358)
CatBoost with physics-based metaheuristics for thyroid cancer recurrence prediction. [PDF]
Sarker P, Choi K, Nahid AA, Samad MA.
europepmc +1 more source
Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study
Time of diagnosis of comorbidities in relation to heart failure. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction. Abstract Aims Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention. Methods and results We identified
Hugo MacGowan +12 more
wiley +1 more source
Transferrin receptor serves a role in promoting PANoptosis in thyroid cancer. [PDF]
Ma S +6 more
europepmc +1 more source
Papillary thyroid cancer in three children [PDF]
Justyna Szmit-Domagalska +5 more
openalex +1 more source
Cancer patients presenting to the emergency department ED with dyspnoea. Among 2153 patients presenting to the ED with dyspnea, 473 (22.0%) had an active or past cancer. Acute heart failure (AHF) was the most common final diagnosis in both groups. Pneumonia and cancer‐related dyspnoea were more common in cancer patients.
Paolo Bima +20 more
wiley +1 more source
Differentiated Thyroid Cancer Is Associated With Sex-specific Immune Response. [PDF]
Shobab L +14 more
europepmc +1 more source
Specific characteristics of HFpEF universal definition in cancer patients. Abstract Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized in cancer patients and survivors, yet it remains underdiagnosed and its epidemiology largely unknown.
Kalliopi Keramida +21 more
wiley +1 more source
RETRACTION: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer. [PDF]
Imaging CMM.
europepmc +1 more source
Aims Major adverse cardiovascular events (MACE) related to cardiovascular disease are a major cause of death in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We explored the impact of MASLD on incident MACE and overall mortality in the general population in Germany.
Yvonne Huber +15 more
wiley +1 more source

